CAD 0.43
(6.25%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -18.94 Million CAD | -428.29% |
2022 | -3.58 Million USD | 78.61% |
2021 | -16.76 Million CAD | -109.45% |
2020 | -8 Million CAD | 23.77% |
2019 | -10.49 Million CAD | -1587.76% |
2018 | 705.66 Thousand CAD | -55.22% |
2017 | 1.57 Million CAD | 132.61% |
2016 | -4.83 Million CAD | -1556.53% |
2015 | -291.73 Thousand CAD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -2.12 Million USD | 61.61% |
2024 Q2 | -3.17 Million USD | -49.84% |
2023 Q2 | -4.9 Million USD | -77.49% |
2023 Q1 | -2.76 Million USD | 41.08% |
2023 FY | -18.94 Million CAD | -428.29% |
2023 Q4 | -5.52 Million USD | -1502.94% |
2023 Q3 | -344.79 Thousand USD | 92.97% |
2022 Q3 | -851.85 Thousand CAD | -113.94% |
2022 Q1 | -6.47 Million CAD | -17.45% |
2022 Q2 | -398.18 Thousand CAD | 93.85% |
2022 FY | -3.58 Million USD | 78.61% |
2022 Q4 | -4.69 Million USD | -450.59% |
2021 Q1 | -4.01 Million CAD | -78.67% |
2021 Q2 | -3.23 Million CAD | 19.35% |
2021 Q3 | -3.88 Million CAD | -19.81% |
2021 Q4 | -5.51 Million CAD | -42.19% |
2021 FY | -16.76 Million CAD | -109.45% |
2020 Q1 | -1.8 Million CAD | 26.89% |
2020 Q3 | 800.03 Thousand CAD | 117.27% |
2020 Q4 | -2.24 Million CAD | -380.93% |
2020 Q2 | -4.63 Million CAD | -156.68% |
2020 FY | -8 Million CAD | 23.77% |
2019 Q1 | -2.29 Million CAD | 0.0% |
2019 FY | -10.49 Million CAD | -1587.76% |
2019 Q4 | -2.46 Million CAD | -33.92% |
2019 Q3 | -1.84 Million CAD | 50.69% |
2019 Q2 | -3.73 Million CAD | -63.06% |
2018 FY | 705.66 Thousand CAD | -55.22% |
2017 FY | 1.57 Million CAD | 132.61% |
2016 FY | -4.83 Million CAD | -1556.53% |
2015 FY | -291.73 Thousand CAD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Therma Bright Inc. | -3.76 Million CAD | -402.796% |
Theralase Technologies Inc. | -4.57 Million CAD | -314.454% |
VentriPoint Diagnostics Ltd. | -4.87 Million CAD | -288.843% |